Overview

A Study of Efficacy and Safety With the Transdermal Contraceptive System Versus Mercilon.

Status:
Completed

Trial end date:
1999-03-01

Target enrollment:

Participant gender:

Summary

The purpose of the study was to compare the contraceptive efficacy and safety of the transdermal patch to Mercilon.

Phase:

Phase 3

Details

Lead Sponsor:

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

Treatments:

Contraceptive Agents
Dacuronium
Estradiol
Estradiol 17 beta-cypionate
Estradiol 3-benzoate
Estradiol valerate
Ethinyl Estradiol
Norelgestromin
Polyestradiol phosphate